Comparative analysis of the risk of osteoporotic fractures with proton pump inhibitor use and histamine-2 receptor antagonist therapy in elderly women: A nationwide population-based nested case-control study

被引:8
作者
Park, Joo-Hyun [1 ]
Song, Yun-Mi [2 ]
Jung, Jin-Hyung [3 ]
Han, Kyungdo [4 ]
机构
[1] Korea Univ, Coll Med, Dept Family Med, Ansan Hosp, Ansan, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Dept Family Med, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea
[3] Catholic Univ, Dept Biostat, Coll Med, Seoul, South Korea
[4] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea
关键词
Fractures; Gastroesophageal reflux; Histamine-2 receptor antagonist; Osteoporosis; Proton pump inhibitor; BONE-MINERAL DENSITY; HIP FRACTURE; VITAMIN-B-12; OMEPRAZOLE; MEDICATIONS; ABSORPTION; SECRETION; INCREASE; HEALTH; DRUGS;
D O I
10.1016/j.bone.2020.115306
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The influence of proton pump inhibitors (PPIs) on the risk of osteoporotic fractures remains to be elucidated, especially in the Asian population. This study evaluated the risk of osteoporotic fractures in elderly female Korean PPI users compared to histamine-2 receptor antagonist (H2RA) users, as well as the relationship between fractures and the duration, dose, and pattern of use of PPI. We screened a nationwide cohort of elderly Korean women who underwent bone mineral density measurements during their 66-year-old life-transition medical examination between 2009 and 2014. Study subjects included 8903 cases diagnosed with new osteoporotic fractures and 44,515 matched controls (1:5 ratio based on cohort entry date, follow-up duration, and baseline osteoporosis status) without fractures. They were followed up until 2015. Information on the exposure to PPI or H2RA, occurrence of fracture, and covariates were obtained from the Korean National Health Insurance Service data. Covariate-adjusted odds ratio (aOR) and 95% confidence interval (CI) were estimated using conditional logistic regression analysis. PPI use was associated with an increased risk of osteoporotic fractures (aOR: 1.13, 95% CI: 1.07, 1.18) compared with H2RA-only use. Increasing duration of PPI use was positively associated with the risk of osteoporotic fracture [aOR (95% CI) of long-term PPI use (>= 1 year): 1.3 (1.09, 1.56)]. Recent PPI use within the last year was associated with an increased risk of fracture (aOR: 1.31, 95% CI: 1.23, 1.38), whereas remote PPI use was not (aOR: 0.98, 95% CI: 0.92, 1.04). The risk of fracture did not increase with the increasing cumulative PPI dose. Compared with the use of H2RA alone, PPI use was associated with an increased risk of osteoporotic fractures in elderly Korean women, particularly among those who had used PPI within the last year or for more than one year.
引用
收藏
页数:9
相关论文
共 58 条
[1]   Enteral vitamin B12 supplements reverse postgastrectomy B12 deficiency [J].
Adachi, S ;
Kawamoto, T ;
Otsuka, M ;
Todoroki, T ;
Fukao, K .
ANNALS OF SURGERY, 2000, 232 (02) :199-201
[2]   Proton-pump inhibitor use and hip fractures in men: a population-based case-control study [J].
Adams, Annette L. ;
Black, Mary Helen ;
Zhang, Jian L. ;
Shi, Jiaxiao M. ;
Jacobsen, Steven J. .
ANNALS OF EPIDEMIOLOGY, 2014, 24 (04) :286-290
[3]   Cardioprotective effects of light-moderate consumption of alcohol: A review of putative mechanisms [J].
Agarwal, DP .
ALCOHOL AND ALCOHOLISM, 2002, 37 (05) :409-415
[4]   Vitamin B12 (cobalamin) deficiency in elderly patients [J].
Andrès, E ;
Loukili, NH ;
Noel, E ;
Kaltenbach, G ;
Ben Abdelgheni, M ;
Perrin, AE ;
Noblet-Dick, M ;
Maloisel, F ;
Schlienger, JL ;
Blicklé, JF .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (03) :251-259
[5]   Ethnic difference of clinical vertebral fracture risk [J].
Bow, C. H. ;
Cheung, E. ;
Cheung, C. L. ;
Xiao, S. M. ;
Loong, C. ;
Soong, C. ;
Tan, K. C. ;
Luckey, M. M. ;
Cauley, J. A. ;
Fujiwara, S. ;
Kung, A. W. C. .
OSTEOPOROSIS INTERNATIONAL, 2012, 23 (03) :879-885
[6]   Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis [J].
Chen, C. -H. ;
Lin, C. -L. ;
Kao, C. -H. .
OSTEOPOROSIS INTERNATIONAL, 2016, 27 (06) :2117-2126
[7]   Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study [J].
Chiu, Hui-Fen ;
Huang, Ya-Wen ;
Chang, Chih-Ching ;
Yang, Chun-Yuh .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (11) :1131-1136
[8]   Proton Pump Inhibitors and Histamine-2 Receptor Antagonists Are Associated With Hip Fractures Among At-Risk Patients [J].
Corley, Douglas A. ;
Kubo, Ai ;
Zhao, Wei ;
Quesenberry, Charles .
GASTROENTEROLOGY, 2010, 139 (01) :93-101
[9]   Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates [J].
de Vries, F. ;
Cooper, A. L. ;
Cockle, S. M. ;
van Staa, T-P. ;
Cooper, C. .
OSTEOPOROSIS INTERNATIONAL, 2009, 20 (12) :1989-1998
[10]   The Relationship Between Proton Pump Inhibitor Adherence and Fracture Risk in the Elderly [J].
Ding, Jian ;
Heller, Debra A. ;
Ahern, Frank M. ;
Brown, Theresa V. .
CALCIFIED TISSUE INTERNATIONAL, 2014, 94 (06) :597-607